Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gastrointestinal Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Featuring an interview with Dr Philip A Philip, including the following topics: Comprehensive biomarker analysis for patients diagnosed with colorectal cancer (CRC) (0:00) Selection of first-line therapy for patients with metastatic CRC (mCRC) (7:51) Therapeutic options for patients with HER2-positive mCRC (10:10) Patient selection for regorafenib and/or TAS-102 with or without bevacizumab for mCRC (16:57) Selection and sequencing of therapeutic options for patients with unresectable or metastatic gastric or gastroesophageal junction cancer (19:52) Current and emerging immune checkpoint inhibitor-based combinations for hepatocellular carcinoma (24:51) First- and later-line therapy for patients with advanced biliary tract cancers (33:17) Activity of NALIRIFOX (liposomal irinotecan/oxaliplatin/leucovorin/fluorouracil) for treatment-naïve metastatic pancreatic cancer (36:12) CME information and select publications